investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
A novel mouse model to identify biomarkers of IPMN formation and progression
Maike Sander
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark A Valasek
University of California, San Diego
San Diego, United States
Janel Kopp
University of British Columbia
Vancouver, Canada
Oliver Harismendy
University of California, San Diego
San Diego, United States
Maike Sander
University of California, San Diego
San Diego, United States
Related projects
Philip D Greenberg
Mechanisms of Murine Turmor Eradication by Immunotherapy
Pancreas
Pathology
Kathleen M Mulder
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
Pancreas
Pathology
Keping Xie
Functional Validation of Pancreatic Cancer Progression Biomarker
Pancreas
Pathology
Keping Xie
Molecular Mediators of Pancreatic Cancer Invasion and Progression
Pancreas
Pathology
Vladimir Bogdanov
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
Pancreas
Pathology
Channing J Der
Identification of synthetic lethal interactors in pancreatic cancer
Pancreas
Pathology
Udo Rudloff
Preclinical Drug Development in Pancreatic Cancer
Pancreas
Pathology
Anthony G Letai
Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
Pancreas
Pathology
Peng Wei
Genetic Susceptibility and Risk Model for Pancreatic Cancer
Pancreas
Pathology
